February 27, 2023 February 27, 2023Categories Announcements News StoriesThe TAILORx trial continues to provide reassurance that many women with early breast cancer can safely forego chemotherapy
February 23, 2023 February 23, 2023Categories News StoriesA focus on the DREAMseq trial reveals data-driven clinical insights into the selection of first-line treatment options for patients with BRAF-mutated metastatic melanoma
February 10, 2023 February 10, 2023Categories Announcements News StoriesThe January/February 2023 News from ECOG-ACRIN blog is now available
February 6, 2023 February 6, 2023Categories News StoriesOngoing Trial: The INSIGNA clinical trial is testing the timing of immunotherapy alone or with chemotherapy for patients with advanced lung cancer
January 30, 2023 January 30, 2023Categories News StoriesNow Enrolling: The BRIDGE research study is evaluating a new treatment approach for patients with early bladder cancer
January 24, 2023 January 24, 2023Categories News StoriesBlinatumomab significantly improves overall survival in newly diagnosed B-ALL patients who are MRD-negative after initial treatment (study E1910)
January 5, 2023 January 5, 2023Categories Announcements News StoriesThe Winter 2023 advocacy blog Considering Clinical Trials is now available
December 20, 2022 December 20, 2022Categories Announcements News StoriesThe November/December 2022 News from ECOG-ACRIN blog is now available
December 19, 2022 December 19, 2022Categories News StoriesBlinatumomab Plus Consolidation Chemotherapy Significantly Reduces Risk of Death in MRD-Negative B-Cell ALL
